Imunon (IMNN) Share-based Compensation (2010 - 2026)
Imunon's (IMNN) quarterly Share-based Compensation came in at $400000.0 in Q1 2026, up 95.57% YoY from $204533.0 in Q1 2025, and up 1311.73% on a QoQ basis from $28334.0 in Q4 2025.
Imunon (IMNN) Share-based Compensation (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Share-based Compensation data on file, last reported at $400000.0 in Q1 2026.
- Quarterly Share-based Compensation rose 95.57% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $400000.0 (down 4.84% YoY) and the FY2025 annual result came in at $127374.0, down 74.53% from the prior year.
- Share-based Compensation climbed to $400000.0 in Q1 2026, from $28334.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $994614.0 in Q1 2022 to a low of -$30679.0 in Q1 2024.
- A 5-year average of $371673.3 and a median of $400000.0 in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation sank 109.06% — and 2025, when it jumped 766.69%.
- Tracing IMNN's Share-based Compensation over 5 years: stood at $710240.0 in 2022, then slumped by 81.21% to $133424.0 in 2023, then slipped by 15.25% to $113079.0 in 2024, then tumbled by 74.94% to $28334.0 in 2025, then jumped by 1311.73% to $400000.0 in 2026.
- The last three Share-based Compensation figures came in at $400000.0 (Q1 2026), $28334.0 (Q4 2025), and $58000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Imunon | 8.16 Mn | 8.16 Mn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 28,334.00 |
| Dec 31, 2025 | 28,334.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 204,533.00 |
| Mar 31, 2025 | 204,533.00 |
| Dec 31, 2024 | 113,079.00 |
| Dec 31, 2024 | 113,079.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | -30,679.00 |
| Mar 31, 2024 | -30,679.00 |